-
Staurosporine as a Kinase Mapping Tool
2026-09-30
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor that can help distinguish kinase-dependent motility from nonspecific cytotoxicity. This article connects its assay utility with new findings on TBXA2R–ERM signaling in triple-negative breast cancer and provides a rigorous workflow for cancer research.
-
Separating Growth Arrest from Cancer Cell Death
2026-09-30
Hannah R. Schwartz’s dissertation shows why reduced viability should not be treated as a direct measure of cancer cell killing. By distinguishing relative viability from fractional viability and considering response timing, the study provides a more informative framework for interpreting anticancer drug effects in vitro.
-
Cyanine 3 Tyramide for Comparative ISH
2026-09-29
Cyanine 3 Tyramide combines localized Tyramide Signal Amplification with orange fluorescence for sensitive biomedical research. This article explains how it can support cross-species in situ hybridization while preserving the anatomical context needed for comparative neurobiology.
-
Cy3-dCTP for Direct DNA and cDNA Labeling
2026-09-29
Cy3-dCTP enables direct fluorescent incorporation into PCR products, cDNA, and Nick Translation probes without a separate conjugation step. This practical guide combines ratio optimization, workflow-specific controls, and a DNA-framework concept that may improve accessibility in emerging enzymatic synthesis assays.
-
Polygodial for TRPA1 Assays: Reliable Workflow
2026-09-28
A practical guide to using Polygodial (SKU B7311) in TRPA1 signaling studies without confusing channel activation with cytotoxicity. It covers controls, solution handling, interpretation, and supplier-selection criteria grounded in the available product information and literature.
-
Trypsin-Responsive Nanomedicine for Acute Pancreatitis
2026-09-27
Wang and colleagues developed a mesoporous organosilica nanoparticle that combines pancreatic acinar-cell targeting with trypsin-triggered release of the calcium chelator BAPTA-AM. In a mouse model of acute pancreatitis, the system reduced calcium overload and pancreatic injury while improving survival, although its clinical relevance and long-term safety remain to be established.
-
Dimethyloxalylglycine (DMOG): Practical Use
2026-09-26
Dimethyloxalylglycine (DMOG) is a cell-permeable PHD inhibitor used to stabilize HIF and investigate oxygen-sensing and hypoxia-related responses in controlled experiments. It is for research workflows only, not for diagnostic or medical use, and the available product information does not establish a universal dose or schedule across models.
-
Calpain–BDNF/TrkB Disruption After Maternal Surgery
2026-09-26
A 2025 rat study links maternal non-obstetric surgery during pregnancy to offspring cognitive deficits, hippocampal structural changes, and increased calpain activity with reduced BDNF/TrkB signaling. Postnatal calpain inhibition or TrkB activation partially improved these outcomes, identifying a pathway for further mechanistic and neuroprotection research rather than establishing a clinical treatment.
-
Capsazepine Targets MCL1 in Tamoxifen Resistance
2026-09-25
The 2026 study identifies capsazepine as a candidate MCL1 inhibitor through virtual screening followed by cellular and target-engagement experiments. In tamoxifen-resistant breast cancer cells, capsazepine promoted apoptosis and enhanced tamoxifen activity, supporting further investigation of MCL1-directed combination strategies while leaving important questions about in vivo efficacy and clinical relevance unresolved.
-
NHS-Biotin for Polybody Assay Workflows
2026-09-25
Use NHS-Biotin to add a compact streptavidin-detectable handle to nanobodies and engineered polybodies—without confusing labeling with the assembly process itself. This workflow connects peptidisc-assisted multimer design to practical detection and purification, with controls to protect binding activity and interpret avidity fairly.
-
GSK3 Inhibition Restrains Intracellular M. tuberculosis
2026-09-24
The study links host glycogen synthase kinase 3 (GSK3) activity to Mycobacterium tuberculosis growth inside macrophages, combining a kinase-compound screen with genetic perturbation and phosphoproteomic analysis. Its findings support GSK3 inhibition as a host-directed research strategy, while leaving important questions about mechanism, safety, and in vivo relevance unresolved.
-
Topotecan: Pharmacology and Clinical Evidence
2026-09-24
Kollmannsberger and colleagues reviewed how Topotecan inhibits topoisomerase I, its pharmacokinetic properties, and early clinical evidence in ovarian and small-cell lung cancer. The review connects the drug’s cleavable-complex mechanism to dose-limiting hematologic toxicity and highlights both the promise and unresolved questions of dosing schedules and combination therapy.
-
Canagliflozin (hemihydrate): Assay Guide
2026-09-23
This scenario-based guide explains how Canagliflozin (hemihydrate), SKU C6434, can improve solvent control, assay interpretation, and documentation in cell viability and glucose metabolism research. It also defines the evidence-based boundary between SGLT2-related experiments and unsupported mTOR conclusions.
-
Polygodial for TRPA1 Channel Research
2026-09-23
Polygodial offers a controllable chemical input for connecting TRPA1 activation with calcium influx, NFAT localization, and epithelial inflammatory readouts. This workflow-oriented guide shows how to use it in channel assays while separating direct ion-channel effects from downstream cytokine biology.
-
FeaSion Maps RNA Polymerase II CTD Phosphorylation
2026-09-22
The FeaSion study builds a comparative framework for decoding five RNA polymerase II C-terminal domain phosphorylation sites by integrating interactors, genomic occupancy, CRISPR-FACS screening, and rapid protein replacement. Its results expand the known regulatory network and connect site-specific phosphorylation to transcription, chromatin modifications, and developmental, metabolic, and signaling programs.